Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hoppe

Showing results (171-180 of 287) with videos related to

Pageof 29
Sort By:
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
International Journal of Particle Therapy|November 28, 2019
Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton TherapyCurtis Bryant, Bradford S Hoppe, Randal H Henderson, et al.
The Journal of Experimental Medicine|November 24, 2021
Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulationNouraiz Ahmed, Martin Etzrodt, Philip Dettinger, et al.
Blood|July 2, 2016
Identification of factors promoting ex vivo maintenance of mouse hematopoietic stem cells by long-term single-cell quantificationKonstantinos D Kokkaliaris, Erin Drew, Max Endele, et al.
Acta Oncologica (Stockholm, Sweden)|January 24, 2018
Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual healthClement K Ho, Curtis M Bryant, Nancy P Mendenhall, et al.
Acta Oncologica (Stockholm, Sweden)|May 13, 2020
Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancerShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
JAMA Oncology|January 2, 2025
Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical TrialBradford S Hoppe, Sarah A Milgrom, Lindsay A Renfro, et al.
Pediatric Blood & Cancer|February 10, 2021
Second tumor risk in children treated with proton therapyDaniel J Indelicato, James E Bates, Raymond B Mailhot Vega, et al.
Blood Advances|June 26, 2026
E Lesion or Stage IV disease? An Ongoing Unsettled Issue in Pediatric Hodgkin LymphomaJennifer Seelisch, Christine Mauz-Koerholz, Kara M Kelly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
Pageof 29

Showing results (171-180 of 287) with videos related to

Sort By:
Pageof 29
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
International Journal of Particle Therapy|November 28, 2019
Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton TherapyCurtis Bryant, Bradford S Hoppe, Randal H Henderson, et al.
The Journal of Experimental Medicine|November 24, 2021
Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulationNouraiz Ahmed, Martin Etzrodt, Philip Dettinger, et al.
Blood|July 2, 2016
Identification of factors promoting ex vivo maintenance of mouse hematopoietic stem cells by long-term single-cell quantificationKonstantinos D Kokkaliaris, Erin Drew, Max Endele, et al.
Acta Oncologica (Stockholm, Sweden)|January 24, 2018
Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual healthClement K Ho, Curtis M Bryant, Nancy P Mendenhall, et al.
Acta Oncologica (Stockholm, Sweden)|May 13, 2020
Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancerShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
JAMA Oncology|January 2, 2025
Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical TrialBradford S Hoppe, Sarah A Milgrom, Lindsay A Renfro, et al.
Pediatric Blood & Cancer|February 10, 2021
Second tumor risk in children treated with proton therapyDaniel J Indelicato, James E Bates, Raymond B Mailhot Vega, et al.
Blood Advances|June 26, 2026
E Lesion or Stage IV disease? An Ongoing Unsettled Issue in Pediatric Hodgkin LymphomaJennifer Seelisch, Christine Mauz-Koerholz, Kara M Kelly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
Pageof 29